Clinical and forensic examinations of glycemic marker 1,5-anhydroglucitol by means of high performance liquid chromatography tandem mass spectrometry
Authors:
- Cornelius HessCHCornelius Hess
- Bernd StratmannBSBernd Stratmann
- Wulf QuesterWQWulf Quester
- Burkhard MadeaBMBurkhard Madea
- Frank MusshoffFMFrank Musshoff
- Diethelm TschoepeDTDiethelm Tschoepe
- 1 October 2012
- journal article
- research article
- Published by Elsevier in Forensic Science International
- Vol. 222 (1-3) , 132-136
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Comparison of Two Assays for Serum 1,5-AnhydroglucitolClinica Chimica Acta, 2011
- Disorders of glucose metabolism: post mortem analyses in forensic cases–part IIInternational journal of legal medicine, 2010
- Disorders of glucose metabolism–post mortem analyses in forensic cases: part IInternational journal of legal medicine, 2010
- Determination of glycemic monitoring marker 1,5-anhydroglucitol in plasma by liquid chromatography-electrospray tandem mass spectrometryJournal of Chromatography B, 2008
- Simultaneous determination of glucose, 1,5‐anhydrod‐glucitol and related sugar alcohols in serum by high‐performance liquid chromatography with benzoic acid derivatizationBiomedical Chromatography, 2005
- Diagnostic values of combined glucose and lactate values in cerebrospinal fluid and vitreous humour—our experiencesForensic Science International, 2004
- Circulating 1,5-Anhydroglucitol Levels in Adult Patients With Diabetes Reflect Longitudinal Changes of GlycemiaDiabetes Care, 2004
- Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic controlThe Lancet, 1996
- Serum 1,5-anhydroglucitol (1,5 AG): New clinical marker for glycemic controlDiabetes Research and Clinical Practice, 1994
- High performance liquid chromatographic determination of 1,5‐anhydroglucitol in human plasma for diagnosis of diabetes mellitusBiomedical Chromatography, 1992